Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Lehmann

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
International Journal of Epidemiology|March 28, 2019
The epidemiological transition in Papua New Guinea: new evidence from verbal autopsy studiesHebe N Gouda, Riley H Hazard, Seri Maraga, et al.
Vaccine|August 13, 2021
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infantsKathryn J Britton, Janessa L Pickering, William S Pomat, et al.
Genome Biology and Evolution|October 19, 2018
Moraxella catarrhalis Restriction-Modification Systems Are Associated with Phylogenetic Lineage and DiseaseLuke V Blakeway, Aimee Tan, Rachael Lappan, et al.
Vaccine|May 24, 2021
PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of lifeTasmina Rahman, Camilla de Gier, Tilda Orami, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Frontiers in Immunology|August 27, 2021
Differences in Pneumococcal and <i>Haemophilus influenzae</i> Natural Antibody Development in Papua New Guinean Children in the First Year of LifeKelly M Martinovich, Tasmina Rahman, Camilla de Gier, et al.
The Medical Journal of Australia|February 28, 2021
Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendationsAmanda J Leach, Peter S Morris, Harvey Lc Coates, et al.
BMJ Open|May 20, 2018
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational studyJocelyn Chan, Cattram D Nguyen, Jana Y R Lai, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet. Microbe|August 19, 2022
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing studyStephanie W Lo, Kate Mellor, Robert Cohen, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
International Journal of Epidemiology|March 28, 2019
The epidemiological transition in Papua New Guinea: new evidence from verbal autopsy studiesHebe N Gouda, Riley H Hazard, Seri Maraga, et al.
Vaccine|August 13, 2021
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infantsKathryn J Britton, Janessa L Pickering, William S Pomat, et al.
Genome Biology and Evolution|October 19, 2018
Moraxella catarrhalis Restriction-Modification Systems Are Associated with Phylogenetic Lineage and DiseaseLuke V Blakeway, Aimee Tan, Rachael Lappan, et al.
Vaccine|May 24, 2021
PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of lifeTasmina Rahman, Camilla de Gier, Tilda Orami, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Frontiers in Immunology|August 27, 2021
Differences in Pneumococcal and <i>Haemophilus influenzae</i> Natural Antibody Development in Papua New Guinean Children in the First Year of LifeKelly M Martinovich, Tasmina Rahman, Camilla de Gier, et al.
The Medical Journal of Australia|February 28, 2021
Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendationsAmanda J Leach, Peter S Morris, Harvey Lc Coates, et al.
BMJ Open|May 20, 2018
Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational studyJocelyn Chan, Cattram D Nguyen, Jana Y R Lai, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
The Lancet. Microbe|August 19, 2022
Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing studyStephanie W Lo, Kate Mellor, Robert Cohen, et al.
Pageof 10